107 related articles for article (PubMed ID: 32048589)
1. Six Tips for Giving Good Health Care to Anyone With a Cervix.
Sallans RK
AMA J Ethics; 2020 Feb; 22(2):E168-175. PubMed ID: 32048589
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer prevention in transgender men: a review.
Weyers S; Garland SM; Cruickshank M; Kyrgiou M; Arbyn M
BJOG; 2021 Apr; 128(5):822-826. PubMed ID: 32931650
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
4. A Literature Review of Cervical Cancer Screening in Transgender Men.
Gatos KC
Nurs Womens Health; 2018 Feb; 22(1):52-62. PubMed ID: 29433700
[TBL] [Abstract][Full Text] [Related]
5. Bridging Barriers to Cervical Cancer Screening in Transgender Men: A Scoping Review.
Dhillon N; Oliffe JL; Kelly MT; Krist J
Am J Mens Health; 2020; 14(3):1557988320925691. PubMed ID: 32489142
[TBL] [Abstract][Full Text] [Related]
6. "It Can Promote an Existential Crisis": Factors Influencing Pap Test Acceptability and Utilization Among Transmasculine Individuals.
Peitzmeier SM; Agénor M; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
Qual Health Res; 2017 Dec; 27(14):2138-2149. PubMed ID: 28836483
[TBL] [Abstract][Full Text] [Related]
7. Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians.
Potter J; Peitzmeier SM; Bernstein I; Reisner SL; Alizaga NM; Agénor M; Pardee DJ
J Gen Intern Med; 2015 Dec; 30(12):1857-64. PubMed ID: 26160483
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives.
Agénor M; Peitzmeier SM; Bernstein IM; McDowell M; Alizaga NM; Reisner SL; Pardee DJ; Potter J
Cult Health Sex; 2016 Oct; 18(10):1192-206. PubMed ID: 27142466
[TBL] [Abstract][Full Text] [Related]
9. Understanding Transgender Men's Experiences with and Preferences for Cervical Cancer Screening: A Rapid Assessment Survey.
Seay J; Ranck A; Weiss R; Salgado C; Fein L; Kobetz E
LGBT Health; 2017 Aug; 4(4):304-309. PubMed ID: 28422558
[TBL] [Abstract][Full Text] [Related]
10. Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand.
Carroll R; Tan KKH; Ker A; Byrne JL; Veale JF
Aust N Z J Obstet Gynaecol; 2023 Jun; 63(3):448-453. PubMed ID: 37005094
[TBL] [Abstract][Full Text] [Related]
11. Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, Serbia.
Jovanovic V; Mitrovic Jovanovic A; Zivanovic A; Kocic S; Vasiljevic M; Krasic V
Eur J Gynaecol Oncol; 2017; 38(1):69-75. PubMed ID: 29767868
[TBL] [Abstract][Full Text] [Related]
12. Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data.
Kiran T; Davie S; Singh D; Hranilovic S; Pinto AD; Abramovich A; Lofters A
Can Fam Physician; 2019 Jan; 65(1):e30-e37. PubMed ID: 30674526
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer in a transgender man: lessons learnt to improve care.
Barrison L; Hoskins E
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38508608
[TBL] [Abstract][Full Text] [Related]
14. Pap test use is lower among female-to-male patients than non-transgender women.
Peitzmeier SM; Khullar K; Reisner SL; Potter J
Am J Prev Med; 2014 Dec; 47(6):808-12. PubMed ID: 25455121
[TBL] [Abstract][Full Text] [Related]
15. Attitudes of transgender men and non-binary people to cervical screening: a cross-sectional mixed-methods study in the UK.
Berner AM; Connolly DJ; Pinnell I; Wolton A; MacNaughton A; Challen C; Nambiar K; Bayliss J; Barrett J; Richards C
Br J Gen Pract; 2021 Aug; 71(709):e614-e625. PubMed ID: 34001539
[TBL] [Abstract][Full Text] [Related]
16. Breast and Cervical Cancer Screening Disparities in Transgender People.
Oladeru OT; Ma SJ; Miccio JA; Wang K; Attwood K; Singh AK; Haas-Kogan DA; Neira PM
Am J Clin Oncol; 2022 Mar; 45(3):116-121. PubMed ID: 35195561
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and mixed analyses to identify factors that affect cervical cancer screening uptake among lesbian and bisexual women and transgender men.
Johnson MJ; Mueller M; Eliason MJ; Stuart G; Nemeth LS
J Clin Nurs; 2016 Dec; 25(23-24):3628-3642. PubMed ID: 27240268
[TBL] [Abstract][Full Text] [Related]
18. Enacting power and constructing gender in cervical cancer screening encounters between transmasculine patients and health care providers.
Peitzmeier SM; Bernstein IM; McDowell MJ; Pardee DJ; Agénor M; Alizaga NM; Reisner SL; Potter J
Cult Health Sex; 2020 Dec; 22(12):1315-1332. PubMed ID: 31661659
[TBL] [Abstract][Full Text] [Related]
19. Gynecologic Health Care Providers' Willingness to Provide Routine Care and Papanicolaou Tests for Transmasculine Individuals.
Shires DA; Prieto L; Woodford MR; Jaffee KD; Stroumsa D
J Womens Health (Larchmt); 2019 Nov; 28(11):1487-1492. PubMed ID: 31411513
[No Abstract] [Full Text] [Related]
20. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
Charkhchi P; Schabath MB; Carlos RC
J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
